These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31587789)

  • 1. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.
    Alexander KM; Evangelisti A; Witteles RM
    Cardiol Clin; 2019 Nov; 37(4):487-495. PubMed ID: 31587789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexities and Pitfalls in Cardiac Amyloidosis.
    Cuddy SAM; Dorbala S; Falk RH
    Circulation; 2020 Jul; 142(4):409-415. PubMed ID: 32718247
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
    Kourelis TV; Kumar SK; Go RS; Kapoor P; Kyle RA; Buadi FK; Gertz MA; Lacy MQ; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Zeldenrust SR; Rajkumar SV; Dispenzieri A
    Am J Hematol; 2014 Nov; 89(11):1051-4. PubMed ID: 25111004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [AL amyloidosis, from diagnosis to treatment].
    Villesuzanne C; Jaccard A; Nicol M
    Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid cardiomyopathy.
    Karafiatova L; Pika T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in diagnosis and management of cardiac amyloidosis.
    Esplin BL; Gertz MA
    Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
    Herrera GA
    Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
    Joury A; Gupta T; Krim SR
    Curr Probl Cardiol; 2021 Oct; 46(10):100910. PubMed ID: 34175153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
    Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
    Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: approaches to diagnosis and management.
    Desai HV; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Grogan M; Dispenzieri A; Gertz MA
    Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
    Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac amyloidosis-A review of current literature for the practicing physician.
    Ash S; Shorer E; Ramgobin D; Vo M; Gibbons J; Golamari R; Jain R; Jain R
    Clin Cardiol; 2021 Mar; 44(3):322-331. PubMed ID: 33595871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidosis: a case series and review of the literature.
    Senecal JB; Abou-Akl R; Allevato P; Mazzetti I; Hamm C; Parikh R; Woldie I
    J Med Case Rep; 2023 Apr; 17(1):184. PubMed ID: 37081462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.